Welcome to LookChem.com Sign In|Join Free

CAS

  • or

189884-30-8

4-Piperidinecarboxylic acid, 2-methyl-3-oxo-1-(phenylmethyl)-, ethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

189884-30-8 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

  • 4-Piperidinecarboxylic acid, 2-methyl-3-oxo-1-(phenylmethyl)-, ethyl ester

    Cas No: 189884-30-8

  • Need to discuss

  • No requirement

  • Adequate

  • CE Pharm Co.,Ltd
  • Contact Supplier
  • 189884-30-8 Structure

  • Basic information

    1. Product Name: 4-Piperidinecarboxylic acid, 2-methyl-3-oxo-1-(phenylmethyl)-, ethyl ester
    2. Synonyms:
    3. CAS NO:189884-30-8
    4. Molecular Formula: C16H21NO3
    5. Molecular Weight: 275.348
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 189884-30-8.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 4-Piperidinecarboxylic acid, 2-methyl-3-oxo-1-(phenylmethyl)-, ethyl ester(CAS DataBase Reference)
    10. NIST Chemistry Reference: 4-Piperidinecarboxylic acid, 2-methyl-3-oxo-1-(phenylmethyl)-, ethyl ester(189884-30-8)
    11. EPA Substance Registry System: 4-Piperidinecarboxylic acid, 2-methyl-3-oxo-1-(phenylmethyl)-, ethyl ester(189884-30-8)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 189884-30-8(Hazardous Substances Data)

189884-30-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 189884-30-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,9,8,8 and 4 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 189884-30:
(8*1)+(7*8)+(6*9)+(5*8)+(4*8)+(3*4)+(2*3)+(1*0)=208
208 % 10 = 8
So 189884-30-8 is a valid CAS Registry Number.

189884-30-8Downstream Products

189884-30-8Relevant articles and documents

Synthesis and α-adrenergic activity of 2- and 6-methyl-substituted (3,4-dihydroxyphenyl)-3-piperidinols

Macchia, B.,Macchia, M.,Martinelli, A.,Martinotti, E.,Orlandini, E.,et al.

, p. 231 - 240 (1997)

Previous drug-receptor interaction mechanism studies at the molecular level of adrenergic drugs made it possible to construct two three-dimensional molecular models, A and B, using conformationally restrained cyclic analogues of natural catecholamines, including 3-(3,4-dihydroxyphenyl)-3-piperidinol (3-DPP, 3); these models offer useful information about the steric requirements for the direct activation of α1- and α2-adrenergic receptors, respectively.In order to gain further knowledge about the steric requirements of these receptors, we also synthesized 3-(3,4-dihydroxyphenyl)-c-2-methyl-r-3-piperidinol (2-MDPP, 8) and the 3-(3,4-dihydroxyphenyl)-c- and -t-6-methyl-r-3-piperidinols (6-MDPPs 9 and 10); these differ from the 3-DPP 3 used for the construction of the molecular models exclusively in the presence of a methyl in the 2 or 6 position of the heterocyclic ring.The configuration and conformation of the MDPPs 8-10 were assigned by 1H-NMR and IR studies, and confirmed by conformational analysis performed by means of theoretical calculations.The α1- and α2-adrenergic properties were evaluated in vitro both by radioligand binding assays and by functional tests on isolated preparations.The results obtained made it possible to obtain a more refined steric definition of the A and B models. - Keywords: 3-piperidinol derivative; adrenergic α-stimulating activity; conformational analysis; molecular model.

IDH1 mutant micromolecule inhibitor, and preparation method and application thereof

-

Paragraph 0242-0243; 0245, (2019/07/16)

The invention discloses an IDH1 mutant micromolecule inhibitor, and a preparation method and application thereof. The structure of the inhibitor is as shown in a formula I, and the definition of the substituent groups is as described in the specification

KRAS G12C INHIBITORS

-

Paragraph 0640, (2019/05/24)

The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

KRAS G12C INHIBITORS

-

Paragraph 0362, (2017/12/18)

The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.

P2X7 MODULATORS

-

Paragraph 0493, (2014/09/30)

The present invention is directed to a compound of Formula (I) The invention also relates to pharmaceutical compositions comprising compounds of Formula (I). Methods of making and using the compounds of Formula (I) are also within the scope of the invention.

PYRIMIDINONE DERIVATIVES AND METHODS OF USE THEREOF

-

Page/Page column 206, (2008/12/08)

The present invention relates to Pyrimidinone Derivatives, compositions comprising a Pyrimidinone Derivative, and methods of using the Pyrimidinone Derivatives for treating or preventing obesity, diabetes, a metabolic disorder, a cardiovascular disease or a disorder related to the activity of G protein-coupled receptor 119 ("GPR119") in a patient.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 189884-30-8